|
Feasibility of Objective Measures and Outpatient Washout in Disease-Modifying Trials for Parkinsons Disease |
5K01AG066971-02 |
|
NIA |
2022 |
|
Mechanisms Underlying Improved Health Span on a Short-Term Ketogenic Diet |
5P01AG062817-04 |
|
NIA |
2022 |
|
Does vestibular loss predict falls in patients with Alzheimers Disease? |
5R01AG057667-05 |
|
NIA |
2022 |
|
Prevention of Fractures in Patients with Parkinsons Disease |
5R01AG059417-03 |
|
NIA |
2022 |
|
Clinical trial of vestibular therapy to reduce falls in patients with Alzheimers disease |
5R01AG065259-02 |
|
NIA |
2022 |
|
Central cholinergic presbyvestibulopathy network changes and imbalance in Parkinsons disease and older persons |
5R01AG073100-02 |
|
NIA |
2022 |
|
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS) |
7R01AG062770-04 |
|
NIA |
2022 |
|
Feasibility of Objective Measures and Outpatient Washout in Disease-Modifying Trials for Parkinsons Disease |
1 K01 AG066971-01A1 |
|
NIA |
2021 |
|
Multimodal investigation of tau-related vasculopathy in prodromal Alzheimers disease |
1 K01 AG071798-01 |
|
NIA |
2021 |
|
Understanding the structural, functional, and prognostic implications of cortical excitability in Alzheimers disease |
1 K23 AG068364-01A1 |
|
NIA |
2021 |